fashion -WSS

fashion

author：leisure time 2025-09-30 00:09:46 - browse：2655

A new lawsuit accuses the health insurer Cigna of denying claims in bulk. Julia Rendleman/Getty Images for Eventive Marketing

A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid.

The complaint filed Monday in the Eastern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments. The company then allegedly denies claims in bulk without looking into each coverage request. California law requires insurers to give each claim a “thorough, fair, and objective investigation.”

Once the claims are denied, the company allegedly has its physician reviewers sign off on batches of denials without opening each patient’s files to conduct detailed reviews. The complaint cites a March ProPublica article, which found that over a period of two months in 2022, Cigna doctors denied over 300,000 requests for payment using PXDX, spending an average of 1.2 seconds “reviewing” each request. One doctor alone denied 121,000 claims in that time period, according to the article.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

WSS

Why Medicare shouldn’t cover every FDA

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Zyn nicotine pouches become unlikely player in latest culture war

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Military medical care influenced by rank and race, new study finds

New clues to why women have higher risk of autoimmune disorders

focus

fashion

knowledge

Continuity nursing helped my family in our darkest PICU moments

Why Medicare shouldn’t cover every FDA

Hepatitis C has a cure — but many Americans still lack access to it

Reconstructing family trees of blood cells may help predict disease

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

How generative AI ratchets up security threats for health systems

Psychedelics group wrestles with new pharma identity

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Tori Bowie and the unacceptable rates of Black maternal death

Readout Newsletter: CG Oncology IPO, Eli Lilly, Tesla, Merck

leisure time

Investment in vaccine development is lagging, report finds

Bernie Sanders is gearing up to subpoena pharma CEOs

Medicare drug price negotiation legal challenge met with skepticism

Data integrity in scientific journals requires "effort" by publishers, institutions

10 reasons why health care startups fail

When prostate cancer spreads, where it goes matters

knowledge

hotspot

Wikipedia

Wikipedia